- Home
- DERM vs NVX Comparison
DERM vs NVX Comparison
Compare DERM & NVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DERM
- NVX
- Stock Information
- Founded
- DERM 2014
- NVX 2012
- Country
- DERM United States
- NVX Australia
- Employees
- DERM N/A
- NVX N/A
- Industry
- DERM Biotechnology: Pharmaceutical Preparations
- NVX Industrial Machinery/Components
- Sector
- DERM Health Care
- NVX Miscellaneous
- Exchange
- DERM Nasdaq
- NVX Nasdaq
- Market Cap
- DERM 213.6M
- NVX 204.1M
- IPO Year
- DERM 2021
- NVX N/A
- Fundamental
- Price
- DERM $7.85
- NVX $1.14
- Analyst Decision
- DERM Strong Buy
- NVX
- Analyst Count
- DERM 3
- NVX 0
- Target Price
- DERM $12.67
- NVX N/A
- AVG Volume (30 Days)
- DERM 236.1K
- NVX 1.9M
- Earning Date
- DERM 11-12-2025
- NVX 01-01-0001
- Dividend Yield
- DERM N/A
- NVX N/A
- EPS Growth
- DERM N/A
- NVX N/A
- EPS
- DERM N/A
- NVX N/A
- Revenue
- DERM $59,399,000.00
- NVX $5,931,433.00
- Revenue This Year
- DERM $26.16
- NVX $165.90
- Revenue Next Year
- DERM $45.27
- NVX $1,344.85
- P/E Ratio
- DERM N/A
- NVX N/A
- Revenue Growth
- DERM 2.82
- NVX N/A
- 52 Week Low
- DERM $3.54
- NVX $0.81
- 52 Week High
- DERM $9.40
- NVX $3.86
- Technical
- Relative Strength Index (RSI)
- DERM 48.08
- NVX 40.77
- Support Level
- DERM $7.42
- NVX $0.96
- Resistance Level
- DERM $8.18
- NVX $1.24
- Average True Range (ATR)
- DERM 0.49
- NVX 0.09
- MACD
- DERM -0.11
- NVX 0.01
- Stochastic Oscillator
- DERM 27.00
- NVX 49.76
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.
About NVX NOVONIX Limited American Depository Shares
NOVONIX Ltd operates in the lithium-ion battery industry. The company has three operating segments namely Graphite Exploration, Battery Technology, and Battery Materials. Graphite Exploration segment is engaged in the exploration and development of high-grade flake graphite deposits. The Battery Technology segment develops battery cell testing equipment and carries out research and development in battery development. The Battery Materials segment develops and manufactures battery anode materials. The Battery Technology segment generates maximum revenue for the company.